1. Home
  2. NBIX vs CSL Comparison

NBIX vs CSL Comparison

Compare NBIX & CSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$163.88

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Carlisle Companies Incorporated

CSL

Carlisle Companies Incorporated

HOLD

Current Price

$345.98

Market Cap

14.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
CSL
Founded
1992
1917
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Specialty Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
14.0B
IPO Year
1996
1994

Fundamental Metrics

Financial Performance
Metric
NBIX
CSL
Price
$163.88
$345.98
Analyst Decision
Strong Buy
Buy
Analyst Count
22
6
Target Price
$180.91
$401.67
AVG Volume (30 Days)
1.1M
312.0K
Earning Date
05-05-2026
04-23-2026
Dividend Yield
N/A
1.27%
EPS Growth
41.95
N/A
EPS
1.91
3.10
Revenue
$161,626,000.00
$5,003,600,000.00
Revenue This Year
$24.73
$2.59
Revenue Next Year
$13.14
$4.50
P/E Ratio
$87.58
$110.35
Revenue Growth
977.51
9.08
52 Week Low
$122.14
$293.43
52 Week High
$169.57
$435.92

Technical Indicators

Market Signals
Indicator
NBIX
CSL
Relative Strength Index (RSI) 65.15 49.89
Support Level $134.92 $339.39
Resistance Level N/A $344.68
Average True Range (ATR) 4.51 8.73
MACD 0.13 0.93
Stochastic Oscillator 67.18 80.15

Price Performance

Historical Comparison
NBIX
CSL

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About CSL Carlisle Companies Incorporated

Carlisle Companies Inc is a holding company that manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. It operates through two segments: Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The majority of revenue comes from Carlisle Construction Materials, and more than half of total revenue is earned in the United States. Carlisle Construction Materials produces premium single-ply roofing products and warranted roof systems, including EPDM, TPO, PVC membrane, and polyiso insulation. Carlisle Weatherproofing Technologies produces building envelope solutions, including waterproofing, moisture protection products, air/vapor barriers, and spray polyurethane foam systems.

Share on Social Networks: